Alpa Laboratories Ratios

Alpa Laboratories Ltd Ratios

The Alpa Laboratories Ltd Ratios page provides a complete fundamental analysis of Alpa Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Alpa Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Alpa Laboratories Ltd (NSE: ALPA, BSE: 532878) is currently trading at ₹61.70, with a market capitalization of ₹1.32B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Alpa Laboratories Ltd remains a key stock for fundamental analysis using Alpa Laboratories Ltd Ratios.

Alpa Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Alpa Laboratories Ltd P/E ratio currently stands at 11.23, making it one of the most tracked metrics in Alpa Laboratories Ltd Ratios.

Historically, the Alpa Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 11.23
• 2023: 10.46
• 2022: 8.99
• 2021: 10.38
• 2020: 10.50

The rising Alpa Laboratories Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Alpa Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.28.

Historical P/B trend:

• 2024: 1.28
• 2023: 1.16
• 2022: 0.84
• 2021: 1.20

Alpa Laboratories Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Alpa Laboratories Ltd P/S ratio currently stands at 2, an important part of Alpa Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 2
• 2023: 1.63
• 2022: 1.23
• 2021: 1.32

The rising Alpa Laboratories Ltd P/S ratio indicates improved revenue valuation by investors.

Alpa Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Alpa Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 10.69.

Historical Alpa Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 10.69
• 2023: 29.99
• 2022: 11.42
• 2021: 42.02
• 2020: 0

The declining Alpa Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Alpa Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Alpa Laboratories Ltd EV currently stands at ₹1.06B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 1.06B
• 2023: 878.93M
• 2022: 346.18M
• 2021: 785.34M

Alpa Laboratories Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Alpa Laboratories Ltd EV/EBITDA ratio is currently 24.20, a key metric in Alpa Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 24.20
• 2023: 10.24
• 2022: 4.29
• 2021: 8.16

Higher Alpa Laboratories Ltd EV/EBITDA suggests premium valuation.

Alpa Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Alpa Laboratories Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0.03
• 2022: 0.02
• 2021: 0.03

Alpa Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Alpa Laboratories Ltd ROE currently stands at 12.06%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 12.06
• 2023: 11.71
• 2022: 9.82
• 2021: 12.29

Alpa Laboratories Ltd maintains stable profitability levels.

Alpa Laboratories Ltd Ratios Analysis Summary

The Alpa Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Alpa Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Alpa Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.